Evidence map›Paper›PMID 34741004›Full record

ArticleSpinal cord series and cases2021

Recurrence of cervical intramedullary gliofibroma.

Keita Tokunaga, Narihito Nagoshi, Kentaro Ohara, Makoto Shibuya, Satoshi Suzuki, Osahiko Tsuji, Eijiro Okada, Nobuyuki Fujita, Mitsuru Yagi, Kota Watanabe and 2 more

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Spinal cord series and cases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Keita TokunagaDepartment of Orthopaedic Surgery, Keio University School of Medicine, Tokyo, 160-8582, Japan.
Narihito NagoshiDepartment of Orthopaedic Surgery, Keio University School of Medicine, Tokyo, 160-8582, Japan. nagoshi@2002.jukuin.keio.ac.jp.ORCID 0000-0001-8267-5789
Kentaro OharaDepartment of Pathology, Keio University School of Medicine, Tokyo, 160-8582, Japan.
Makoto ShibuyaCentral clinical laboratory, Hachioji medical center, Tokyo medical university, Tokyo, 193-0998, Japan.
Satoshi SuzukiDepartment of Orthopaedic Surgery, Keio University School of Medicine, Tokyo, 160-8582, Japan.
Osahiko TsujiDepartment of Orthopaedic Surgery, Keio University School of Medicine, Tokyo, 160-8582, Japan.
Eijiro OkadaDepartment of Orthopaedic Surgery, Keio University School of Medicine, Tokyo, 160-8582, Japan.
Nobuyuki FujitaDepartment of Orthopaedic Surgery, School of Medicine, Fujita Health University, Aichi, 470-1192, Japan.
Mitsuru YagiDepartment of Orthopaedic Surgery, Keio University School of Medicine, Tokyo, 160-8582, Japan.ORCID 0000-0002-2324-3780
Kota WatanabeDepartment of Orthopaedic Surgery, Keio University School of Medicine, Tokyo, 160-8582, Japan.
Masaya NakamuraDepartment of Orthopaedic Surgery, Keio University School of Medicine, Tokyo, 160-8582, Japan.
Morio MatsumotoDepartment of Orthopaedic Surgery, Keio University School of Medicine, Tokyo, 160-8582, Japan.
Keio University · JPFujita Health University · JPTokyo Medical University Hachioji Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionGliofibroma is a rare tumor that develops in the brain and spinal cord. Due to the rarity of its nature, its pathophysiology and appropriate treatment remain elusive. We report a case of intramedullary spinal cord gliofibroma that was surgically treated multiple times. This report is of great significance because this is the first case of recurrence of this tumor. CASE PRESENTATION: A 32-year-old woman complained of gait disturbance and was referred to our institution. At the age of 13 years, she was diagnosed with intramedullary gliofibroma and underwent gross total resection (GTR) in another hospital. Based on imaging findings, tumor recurrence was suspected at the level of cervical spinal cord, and surgery was performed. However, the resection volume was limited to 50% because the boundary between the tumor and spinal cord tissue was unclear and intraoperative neuromonitoring alerted paralysis. At 1 year postoperatively, the second surgery was performed to try to resect the residual tumor, but subtotal resection was achieved at most. At 2 years after the final surgery, no tumor recurrence was observed, and neurologic function was maintained to gait with cane. DISCUSSION: Although complete resection is desirable for this rare tumor at the initial surgery, there is a possibility to recur even after GTR with long-term follow-up. During surgical treatment for tumor recurrence, fair adhesion to the spinal cord is expected, and reoperation and/or adjuvant therapy might be considered in the future if the tumor regrows and triggers neurological deterioration.

Indexed as

AstrocytomaSpinal Cord NeoplasmsAdolescentAdultFemaleHumansNeurosurgical ProceduresTreatment Outcome

Identifiers

PMID34741004
PMCPMC8571383
OpenAlexW3211277663

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.